Case File
efta-efta01156970DOJ Data Set 9OtherFrom: "Morris, Paul V"
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta01156970
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "Morris, Paul V"
To: Jeffrey Epstein <[email protected]>
CC: "McGraw Thomas"
"Jonathan J. Rikoon
, "Morris, Paul V"
Subject: PPF Follow-up Materials
Date: Mon, 31 Jan 2011 19:49:53 +0000
Attachments: Considerations_in_the_Valuation_of Interests_in_Estate_Freeze_Entities.pdf; PPF_2010_-
_Jeff Epstein_-_4-ppt.zip
Jeffrey,
As promised, attached please find the abbreviated flipbook with comments as to where some of the
assumptions/numbers came from. A few other important notes to consider:.
•
Attached is the white paper from Empire Valuation entitled "Considerations in the Valuation of Interests in Estate
Freeze Entities." The discounts applied in this paper should foot to the discounts used in the generic model that
was provided.
•
With regard to whether there is liquidity with which to pay the preferred payments, as can be seen on page 3 of
the white paper, one doesn't have to assume that the entire balance sheet is illiquid; rather one may assume that
the hypothetical funding value is composed of various asset classes, some of which have realized economic
performance that would provide liquidity for the annual fixed payments to the preferred. The discounts on each
of those asset classes differ, and the discount we assumed on the asset funding is a weighted average of the
discounts assumed on each asset class.
•
Comments are inserted throughout the pages of the deck to facilitate understanding and address questions that
were raised on the call.
•
The economic flows slide on page 12 of the new deck shows the cash flows summarized on slide 11.
Regards,
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and com s leteness of information, viruses confidentiality, legal privilege,
and legal entity disclaimers, available at
EFTA01156970
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.